IMR vs NEU

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IMR

IMRICOR CDI FORUS [IMR]

44LOW

NEU

NEUREN FPO NZ [NEU]

44LOW

Score Breakdown

IMR NEU
Technical
69
77
Catalyst
50
50
Sentiment
50
50
Fundamental
55
60
Momentum
58
22
Risk Gate
45
43

Key Metrics

IMR Metric NEU
$635.5MMarket Cap$1.5B
374KAvg Volume (20d)705K
+0.0%Short Interest+4.4%
$2.25052-Week High$22.985
$1.11552-Week Low$8.610
+5.7%Daily Change+5.1%
$1.945Entry Price$11.880
-1221.3%ROE+8.7%
N/AProfit Margin+47.1%

Active Signals

IMR Signals

●Volume surging at 2.7x normal while price climbs — real buying conviction behind this move
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)
●Very high P/S ratio (2174.0x)
●Revenue in sharp decline (-83%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●CANSLIM I: Institutional ownership (18%)
●Not enough chatter to gauge sentiment — defaulting to neutral

NEU Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Above-average volume (1.8x) on a green day — buyers stepping up
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)

Ask Scout AI to compare IMR and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IMR Full Analysis → NEU Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).